Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03274700
Other study ID # tamsulosin in ureteric stones
Secondary ID
Status Not yet recruiting
Phase Early Phase 1
First received August 27, 2017
Last updated September 5, 2017
Start date October 1, 2017
Est. completion date October 2018

Study information

Verified date August 2017
Source Assiut University
Contact mahmoud eldardery, resident
Phone 01008763519
Email meldardery91@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To estimate the efficacy of tamsulosin in:

A - Expulsion of lower ureteric stones from10-15 mm diameters (primary goal).

B - Pain relief and hyronephrosis improvement (secondary goal).


Description:

Urolithiasis affects 4-15% of world population and the incidence of this disease is increasing day by day . Of all the urinary tract stones, 20% are ureteral stones, and 70% of these ureteral stones are found in the distal part of the ureters . The goal of treatment of patients suffering from ureteral calculi is to achieve complete stone clearance with minimal morbidity .

Ureteral calculi of any size may be associated with renal obstruction and care must be taken to prevent irreversible damage to kidney, whether patient selects expectant or active treatment . An expectant treatment or watchful waiting approach may be expected to produce spontaneous stone expulsion up to 50% of cases but some complications such as urinary infection, hydronephrosis, and repetitive colicky pain may occur . Once a conservative approach proves to be unsuccessful, interventional treatment becomes necessary. After a period of conservative treatment, however, intervention is often inefficient or has a higher risk for complications due to stone impaction and the associated inflammatory reaction of the ureter . Non-invasive treatment with extracorporeal shockwave lithotripsy and minimal invasive approach with ureteroscopy allow ureterolithiasis to resolve in almost all cases but these procedures are not risk free and they require some experience and not cost effective .

The therapeutic potential of α-blockers for ureteral stone disease has been investigated, prompted by the detection of α-receptors in ureteral smooth muscle cells . We choose to focus on tamsulosin because it is the most frequently studied α-blocker, recommended in urology treatment guidelines, and, in our experience, the most common medical expulsive therapy used by emergency physicians .

The objective of this trial was to evaluate the efficacy of MET with tamsulosin for ureteral stones from 10-15 mm diameter in a randomised, placebo-controlled setting.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date October 2018
Est. primary completion date September 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Lower ureteric stones from(10-15) mm diameters.

2. Age group equal or more than 18 years.

3. Normal renal function.

Exclusion Criteria:

1. Lower ureteric stones less than 10mm and more than 15 mm diameters.

2. Age group less than 18 years.

3. Associated ureteric strictures.

4. Febrile urinary tract infections.

5. Severe hydronephrosis.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Tamsulosin.
Patients who will receive tamsulosin as a treatment for lower ureteric stones from (10-15)mm up to 8 weeks duration.
Placebo.
Patients who will receive as placebo a treatment for lower ureteric stones from (10-15)mm up to 8 weeks duration.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Pearle MS. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. Int Braz J Urol. 2004 Nov-Dec;30(6):546-547. — View Citation

Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J. Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis. Ann Emerg Med. 2017 Mar;69(3):353-361.e3. doi: 10.1016/j.annemergmed.2016.06.044. Epub 2016 Sep 8. Review. — View Citation

Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005 Jun;173(6):2010-2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Theraputic effect of tamsulosin as assessed by number of cases of expulsed ureteric stones. Patients who will receive tamsulosin as a treatment for lower ureteric stones from (10-15)mm up to 8 weeks duration.e foll The cases will be followed up as thowing:
In the first month: abdominal ultrasonography every week, KUB abdomen and pelvis for radiopaque stones.
At the end of the second month: abdominal ultrasonography, KUB abdomen and pelvis for radiopaque stones.
At the end of the third month: abdominal ultrasonography, KUB abdomen and pelvis for radiopaque stones, MSCT abdomen and pelvis for radiolucent stones.
1year
See also
  Status Clinical Trial Phase
Recruiting NCT04851171 - Semi-rigid Ureteroscopy Versus Flexible Ureteroscopy For the Treatment of Proximal Ureteric Stone N/A
Completed NCT05218057 - to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy N/A
Completed NCT03704623 - Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Phase 4
Completed NCT06465784 - Laser Lithotripsy for Ureteral Stones Phase 4
Completed NCT03795545 - Ultraslow SWL Versus Slow SWL for Ureteric Stones With High Attenuation Value N/A
Recruiting NCT04759417 - Comparison of CHOKAI vs STONE Score to Predict the Presence of Ureteric Stones in Patients With Renal Colic: A Multi-center Prospective Observational Study
Completed NCT03404986 - Ultrasound Guided Ureteroscopy and Ureteric Stones N/A